RE:If Ceapro needed funding…..but they don't as per their Q3 earnings report...
and if they did, there are lots of opportunities to raise funds by finding commercial interests for their pipeline...Avalyn raised $175M USD in the fall for their IPF pipeline, CEAPRO could do something similar with Y-BG which is of course on "hold", pending, oh by the way, we should have done toxicology testing first...before proceeding to trials
the we need be taken over below liquidation value in an arms length transaction where I was the CEO for years and came back as a board director as we need funds for our pipeline is a sham, over the past 10 years CZO could have raised funds by partnerships if they were serious about advancing PGX
any progress or word on the CoQ10 licencing that was a target for H2 2023? this is not a serious company
lets get a new CEO who is serious about running a business to enhance instead of destroying shareholder value